| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 19 |
| 1 | POTASSIUM CHLORIDE | 13 |
| 2 | POTASSIUM CHLORIDE EXTENDED-RELEASE | 13 |
| 3 | POTASSIUM CHLORIDE ORAL | 13 |
| 4 | POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE | 13 |
| 5 | RAMIPRIL | 13 |
| 6 | WARFARIN | 13 |
| 7 | ALLOPURINOL | 11 |
| 8 | ROSUVASTATIN | 11 |
| 9 | BISOPROLOL FUMARATE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPLONTERSEN | 1 | 0.0057 |
| 1 | CIDOFOVIR ANHYDROUS | 3 | 0.0021 |
| 2 | BALSALAZIDE DISODIUM | 1 | 0.0019 |
| 3 | TEPOTINIB HYDROCHLORIDE | 1 | 0.0014 |
| 4 | PENTOSTATIN | 1 | 0.0010 |
| 5 | EPLERENONE | 10 | 0.0008 |
| 6 | PSYLLIUM HUSK | 1 | 0.0007 |
| 7 | DARUNAVIR ETHANOLATE AND COBICISTAT | 1 | 0.0006 |
| 8 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 3 | 0.0004 |
| 9 | DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Loop Diuretic [EPC] | 22 |
| 1 | Corticosteroid [EPC] | 14 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14 |
| 3 | Angiotensin Converting Enzyme Inhibitor [EPC] | 13 |
| 4 | Osmotic Laxative [EPC] | 13 |
| 5 | Potassium Salt [EPC] | 13 |
| 6 | Aldosterone Antagonist [EPC] | 12 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 11 |
| 8 | Xanthine Oxidase Inhibitor [EPC] | 11 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 1 | Non-Standardized Plant Allergenic Extract [EPC] | 3 | 0.0002 |
| 2 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 3 | 0.0001 |
| 4 | Angiotensin Converting Enzyme Inhibitor [EPC] | 13 | 0.0001 |
| 5 | Antisense Oligonucleotide [EPC] | 1 | 0.0001 |
| 6 | Aldosterone Antagonist [EPC] | 12 | 0.0001 |
| 7 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 8 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 9 | Xanthine Oxidase Inhibitor [EPC] | 11 | 0.0001 |